Healthcare stocks were posting narrow gains today with the NYSE
Healthcare Sector Index adding about 0.3% and shares of healthcare
companies in the S&P 500 rising about 0.1% as a group.
In company news, Shares of Smith and Nephew (
) and Medtronic (
) both fell Thursday after a Wells Fargo analyst today threw cold
water on market speculation the medical device companies are
considering a possible merger.
In a new research note, Wells Fargo analyst Larry Biegelsen
wrote MDT is unlikely to enter a new market unless it believes it
can become a top player in that field, explaining SNN's hip and
knee business is not large enough to make MDT a market leader.
Biegelsen also said MDT does not appear eager to pursue a deal in
order to take advantage of reduced corporate taxes in the UK
compared to the United States.
SNN shares were off nearly 6% at $91.55 each, giving back about
half of its 12% gain over the three previous sessions this week.
MDT also was down, slipping about 1.7% at $62.13 a share in recent
In other sector news,
(+) HALO, FDA removes clinical hold on patient enrollment and
dosing in a Phase II study of its PEGPH20 drug candidate in
patients with pancreatic cancer, allowing the trial to resume under
a revised protocol.
(-) NVAX, Discloses plans for a $100 mln underwritten offering
of its common stock. The company also intends to issue options to
underwriters to buy up to 15 mln additional shares to cover
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.